Clinical Utility of Plasma <i>p</i> ‐tau217 Compared to PET and CSF in the Diagnosis of Cognitive Disorder
In conclusion, plasma p-tau217 significantly impacts the diagnosis and diagnostic confidence of cognitive impairment, offering a less invasive, cost-effective, and accessible alternative to CSF and PET examinations. Its integration into clinical practice holds promise for streamlining diagnostic procedures and optimizing medical resources in real-world memory clinics.
Authors
- Y F Chen
- Yi‐Han Gan
- Rui‐Xin Yao
- Lingling Li (ORCID: https://orcid.org/0000-0001-5193-1081)
- Yuyuan Huang (ORCID: https://orcid.org/0009-0005-3406-4875)
- Y. P. Guo (ORCID: https://orcid.org/0000-0002-8492-4969)
- Jin‐Tai Yu
Institutions
- Huashan Hospital (CN)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_102622
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00